Category Archives: Featured

START findings highlight treatment divide

By on .

“It’s just more scientific evidence to back what we’ve been saying for a long time.” Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, announcing the conclusion of the START trial, which began in 2011 to assess “the best time for healthy HIV-infected people to begin antiretrovirals.” The announcement from the National Institute […]

AIDS vaccine update: With Thai trial, broadly neutralizing antibodies, new technologies and monkeys that met the SIV challenge, “we’re closer than ever”

By on .

NIH AIDS Vaccine Research Program Director: “The future of HIV-1 Vaccines is bright.” In 1997, scientists announced the birth of Dolly the cloned sheep, a computer named Deep Blue beat reigning chess champion Gary Kasparov, and the Hubble telescope brought the far reaches of outer space closer. President Bill Clinton pointed to all of these […]

PrEP should be looked at as “critical component” to address HIV among men who have sex with men, review concludes

By on .

In a “truly watershed period for lesbian gay bisexual and transgender rights and freedoms,” in the global north, the few prevention methods that work for men who have sex with men need to rapidly be taken to scale, particularly pre-exposure prophylaxis, Dr. Chris Beyrer writes in a new piece published in Current Opinions in Infectious […]

Study: Universal testing and treatment in sub-Saharan Africa would pay off in education cost savings alone

By on .

In April 2000, an education professor at the University of Zambia sized up the still growing impact of the HIV epidemic in sub-Saharan Africa and wrote: “Notwithstanding the catastrophic effects that are already being experienced, the full consequences of the pandemic are still to be felt. The storm has been gathering for two decades. In […]

Young investigators unearth important discoveries in global health

By on .

Young investigators and Fogarty students presented select posters on global health at a special gallery during the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Boston last month. The event was sponsored by the National Insitutes of Health Office of AIDS Research, the Accordia Global Health Foundation and the IDSA Education and Research Foundation. In this video interview, Sten Vermund, MD, PhD, director of the Institute for Global Health at Vanderbilt University, discusses one of the student “highlights” of the evening – Krutika Kuppalli, MD, from the University of California, San Diego – and her research on HIV and leptospirosis in Chenai, India.